Category Archives: Stem Cell Research

Windsor, CT (PRWEB) October 15, 2013 Rainbow Scientific, Inc. (RSI) is pleased to offer advanced research products for human mesenchymal stem cell (hMSC) and human embryonic stem cell (hESC) culture from Biological Industries (BI). These chemically defined, non-animal origin culture media have been thoroughly validated to provide superior growth and maintenance of hMSC and hESC cell lines. Extensive quality control ensures reliable performance, lot-to-lot. These systems eliminate contagious health risks from viral agents, mycoplasma and prions and are accepted for clinical applications. Rainbow Scientific is excited to be working with Biological Industries, a cell culture media developer and manufacturer with over 30 years experience and a worldwide presence, says Peter Mousseau, President. Their stem cell culture systems exhibit outstanding performance characteristics. They pair nicely with RSIs other cell culture offerings and strengthen our offering to the biopharmaceutical market. About Rainbow Scientific Rainbow Scientific, Inc. has been a North American distributor of state-of-the-art products and solutions to academic, government, clinical and biotechnology laboratories for over sixteen years. The company provides cell culture and other bioreagents, diagnostic test kits, scientific instruments and database software for applications in cytogenetics, molecular genetics, hemostasis, oncology, pathology and biopharmaceutical development. http://www.rainbowscientific.com/ About Biological Industries Biological Industries … Continue reading →

BEVERLY, MA and TORONTO, ON--(Marketwired - Oct 14, 2013) - Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision laser devices and advanced image analysis systems for the fertility, stem cell and developmental biology research markets, today announced that the Company will be attending the American Society for Reproductive Medicine (ASRM) 69th Annual Meeting taking place in Boston, MA, October 13 - 17, 2013. ASRM is the premiere U.S. meeting on reproductive medicine and an ideal showcase for Hamilton Thorne to launch the Company's new DIMENSIONS II Strict Morphology program for its CASA II systems, as well as showcase its new sperm imaging and analysis software introduced at the European Society for Human Reproduction and Embryology (ESHRE) meeting in London in July 2013. To learn more about Hamilton Thorne's full line of fertility products, including the new DIMENSIONS II and sperm imaging and analysis software, please visit the Company's booth # 323. Focusing on ease of use plus interoperability and consistency with the Company's other software products, DIMENSIONS II Strict Morphology software provides automated and objective morphological classification of sperm according to strict (Tygerberg) criteria and is fully compatible with its next generation CASA II systems. The strict … Continue reading →

Public release date: 15-Oct-2013 [ | E-mail | Share ] Contact: David McKeon dmckeon@nyscf.org 212-365-7440 New York Stem Cell Foundation NEW YORK, NY (October 15, 2013) The New York Stem Cell Foundation (NYSCF) Research Institute has entered into a partnership with the Parkinson's Progression Markers Initiative (PPMI) to build resources for studying Parkinson's disease to accelerate new treatments. Sponsored by The Michael J. Fox Foundation for Parkinson's Research, PPMI is a landmark effort to identify and validate biomarkers of Parkinson's disease. The study is currently under way at 32 clinical sites worldwide with funding from 13 industry partners. NYSCF will generate stem cell lines from PPMI participants, allowing researchers to examine how Parkinson's disease develops in and progresses in a large and genetically diverse group of patients. This research could potentially lead to the development of treatments tailored to different subtypes of PD. To accelerate discovery and drug development, these stem cell lines will be made available, with de-identified patient data, to the scientific community at large. "To prevent or slow the progression of Parkinson's disease, we need to elucidate the pathobiology of PD," said Ken Marek, PhD, principal investigator of PPMI and senior scientist and co-founder of the Institute … Continue reading →

Neural stem cells can be produced in a week instead of months, with a new product from Life Technologies. Carlsbad-based Life Tech says its product will speed development of treatments for brain injuries and diseases. A team of researchers led by Life Tech scientists published their findings Thursday in the journal Stem Cells Translational Medicine. The study was led by Mohan C. Vemuri, a director of research and development at the company. The method is far superior to many of the most common methods used to make neural stem cells, said Paul Knoepfler, a stem cell scientist at UC Davis. Knoepfler was not involved in the research. "There is a strong need for human neural stem and progenitor cells as well as differentiated human brain cells," Knoepfler wrote in an an email after reviewing the research. "It is important to note that on the Life Technologies website the product is still listed as a 'prototype' so it'll be critical to see how this product functions in the 'real world' of a relatively larger number of research labs." Parkinson's disease is a major focus of stem cell therapies. The goal is to replace neurons that make the neurotransmitter dopamine, which are … Continue reading →

Public release date: 10-Oct-2013 [ | E-mail | Share ] Contact: Michael C. Purdy purdym@wustl.edu 314-286-0122 Washington University School of Medicine New research has shown that the stomach naturally produces more stem cells than previously realized, likely for repair of injuries from infections, digestive fluids and the foods we eat. Stem cells can make multiple kinds of specialized cells, and scientists have been working for years to use that ability to repair injuries throughout the body. But causing specialized adult cells to revert to stem cells and work on repairs has been challenging. Scientists from Washington University School of Medicine in St. Louis and Utrecht Medical Center in the Netherlands report in the new study that a class of specialized cells in the stomach reverts to stem cells more often than they thought. "We already knew that these cells, which are called chief cells, can change back into stem cells to make temporary repairs in significant stomach injuries, such as a cut or damage from infection," said Jason Mills, MD, PhD, associate professor of medicine at Washington University. "The fact that they're making this transition more often, even in the absence of noticeable injuries, suggests that it may be easier … Continue reading →

23 hours ago Foregut stem cells (green) differentiated into pancreatic cells expressing insulin. The development method pioneered by Cambridge researchers enables the production of an uncontaminated population of foregut cells, which could then be further differentiated as pancreatic cells for therapeutic use. Credit: Nicholas Hannan A new method for creating stem cells for the human liver and pancreas, which could enable both cell types to be grown in sufficient quantities for clinical use, has been developed by scientists. Using the technique, researchers have for the first time been able to grow a pure, self-renewing population of stem cells specific to the human foregut, the upper section of the human digestive system. These so-called "Foregut stem cells" could then be developed further to produce liver or pancreatic cells. The method significantly improves on existing techniques for cultivating this type of stem cell, and raises the possibility that, with further work, they could be grown in large numbers in bioreactors. That would make it possible to use them for regenerative therapies, repairing damaged organs or tissues in the body, and treating conditions such as type I diabetes or liver disease. "We have developed a cell culture system which allows us to specifically … Continue reading →

Public release date: 10-Oct-2013 [ | E-mail | Share ] Contact: Mary Beth O'Leary moleary@cell.com 617-397-2802 Cell Press Human skin must cope with UV radiation from the sun and other harmful environmental factors that fluctuate in a circadian manner. A study published by Cell Press on October 10th in the journal Cell Stem Cell has revealed that human skin stem cells deal with these cyclical threats by carrying out different functions depending on the time of day. By activating genes involved in UV protection during the day, these cells protect themselves against radiation-induced DNA damage. The findings could pave the way for new strategies to prevent premature aging and cancer in humans. "Our study shows that human skin stem cells posses an internal clock that allows them to very accurately know the time of day and helps them know when it is best to perform the correct function," says study author Salvador Aznar Benitah an ICREA Research Professor who developed this project at the Centre for Genomic Regulation (CRG, Barcelona), and who has recently moved his lab to the Institute for Research in Biomedicine (IRB Barcelona). "This is important because it seems that tissues need an accurate internal clock to … Continue reading →

SAN DIEGO, CALIF., Oct. 10, 2013 (GLOBE NEWSWIRE) -- Genetics Policy Institute (GPI), producer of the annual World Stem Cell Summit, and Stemedica Cell Technologies, Inc., a leader in adult allogeneic stem cell manufacturing, research and clinical development, announced today that Stemedica will serve as the exclusive sponsor of the Poster Forum at the 2013 World Stem Cell Summit, December 4-6, at the Manchester Grand Hyatt San Diego. As part of its sponsorship, Stemedica has contributed $5,000 in prize money to winning posters. Bernard Siegel, executive director of the Genetics Policy Institute (GPI) and founder and co-chair of the Summit said, "The World Stem Cell Summit is a mission-driven event uniting the global stem cell community to chart the future of regenerative medicine. The annual Poster Forum aims at presenting cutting-edge research and original ideas to move the field forward to accelerate cures. Stemedica's sponsorship of the Poster Forum evidences its commitment to growing the entire field by supporting innovation and responsible research." "We are honored to again be associated with the World Stem Cell Summit, one of the most important meetings for the stem cell community," stated Maynard Howe, Ph.D., CEO and Vice Chairman of Stemedica. "We are committed … Continue reading →

NORTHRIDGE, CA and CAMBRIDGE, UK--(Marketwired - Oct 9, 2013) - Regenerative medicine company Avita Medical Ltd. (ASX: AVH) (OTCQX: AVMXY) today announced that it will be presenting at the upcoming 2013 Stem Cell Meeting on the Mesa. The event will take place on October 14-16, 2013 at the Estancia La Jolla Hotel in La Jolla, California. The Company will be presenting in Track 1 at 11:30 AM on Monday, October 14th as part of the conference's 3rd Annual Regen Med Partnering Forum.Presentation will be live-streamed on the day of the program. "We are pleased to be presenting at this leading regenerative medicine industry conference," said Dr. William Dolphin, Avita Medical's CEO. "ReCell SprayOn Skin is on the market in other countries and undergoing FDA clinical trials in the US. This conference is a great venue to generate awareness among potential corporate partners and institutional investors as we approach FDA submission." This is a three-day conference organized annually by the Alliance for Regenerative Medicine, the California Institute for Regenerative Medicine and the Sanford Consortium for Regenerative Medicine with the intention of bringing together senior members of the regenerative medicine industry with the scientific research community to advance stem cell science into … Continue reading →

LOS ANGELES , Oct. 9, 2013 /CNW/ - Dr. Rongxiang Xu , the founder of "human body regenerative restoration science" and the patentee of damaged organ regeneration- a top priority claimed in President Obama's 2013 State of the Union, addresses the ongoing lawsuit against Nobel Committee and its continuous false advertisement of fake pluripotent stem cell during the past year since Dr. Xu initially filed his lawsuit against the Academy citing, among other claims, libel and unfair competition. Given the winners of 2013 Nobel Prize in Physiology or Medicine were disclosed this week and the Nobel Assembly has not yet made any clarification on its 2012 Prize in Medicine while continuing with its endorsement and false advertisement of fake pluripotent stem cells, Dr. Xu had to come out and tell the public why he sued the Nobel Assembly in 2012 and the progress of the lawsuit. On October 8, 2012 , The Nobel Assembly awarded the Nobel Prize in Physiology or Medicine to Shinya Yamanaka and another expert in nuclear transfer for artificially creating the pluripotency of human somatic cells. In the awarding press release and advertising documentary, the Nobel Assembly stated clearly that the prize winner successfully converted somatic … Continue reading →